首页> 外文期刊>Hypertension research: Official journal of the Japanese Society of Hypertension >EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress
【24h】

EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress

机译:EPA:DHA 6:1预防大鼠血管紧张素II诱导的高血压和内皮功能障碍:NADPH氧化酶和COX衍生的氧化应激的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Eicosapentaenoic acid:docosahexaenoic acid (EPA:DHA) 6:1, an omega-3 polyunsaturated fatty acid formulation, has been shown to induce a sustained formation of endothelial nitric oxide (NO) synthase-derived NO, a major vasoprotective factor. This study examined whether chronic intake of EPA:DHA 6:1 prevents hypertension and endothelial dysfunction induced by angiotensin II (Ang II) in rats. Male Wister rats received orally corn oil or EPA:DHA 6:1 (500 mg kg(-1) per day) before chronic infusion of Ang II (0.4 mg kg(-1) per day). Systolic blood pressure was determined by tail cuff sphingomanometry, vascular reactivity using a myograph, oxidative stress using dihydroethidium and protein expression by immunofluorescence and western blot analysis. Ang II-induced hypertension was associated with reduced acetylcholine-induced relaxations of secondary branch mesenteric artery rings affecting the endothelium-dependent hyperpolarization (EDH)- and the NO-mediated relaxations, both of which were improved by the NADPH oxidase inhibitor VAS-2870. The Ang II treatment induced also endothelium-dependent contractile responses (EDCFs), which were abolished by the cyclooxygenase (COX) inhibitor indomethacin. An increased level of vascular oxidative stress and expression of NADPH oxidase subunits (p47(phox) and p22(phox)), COX-1 and COX-2, endothelial NO synthase and Ang II type 1 receptors were observed in the Ang II group, whereas SKCa and connexin 37 were downregulated. Intake of EPA:DHA 6:1 prevented the Ang II-induced hypertension and endothelial dysfunction by improving both the NO-and EDH-mediated relaxations, and by reducing EDCFs and the expression of target proteins. The present findings indicate that chronic intake of EPA:DHA 6:1 prevented the Ang II-induced hypertension and endothelial dysfunction in rats, most likely by preventing NADPH oxidase-and COX-derived oxidative stress.
机译:eicosapentaeno酸:二十二碳甲酸(EPA:DHA)6:1,已经显示了ω-3多不饱和脂肪酸制剂,诱导持续形成内皮一氧化氮(NO)合成酶衍生的NO,其主要的血压保护剂。本研究检查了EPA的慢性摄入量:DHA 6:1是否可防止大鼠血管紧张素II(Ang II)诱导的高血压和内皮功能障碍。雄性饮料大鼠接受口服玉米油或EPA:DHA 6:1(每天500毫克Kg(-1)),慢性输注Ang II(每天0.4mg kg(-1))。收缩压通过尾部袖口鞘散测定法测定,血管反应性使用诸如Imograph,使用免疫荧光和蛋白质印迹分析使用二氢羟甲酸和蛋白质表达的氧化胁迫。 Ang II诱导的高血压与减少的乙酰胆碱诱导的次生分离肠系膜动脉环的松弛相关,影响内皮依赖性超极化(EDH) - 并且无介导的弛豫,两者都是通过NADPH氧化酶抑制剂VAS-2870改善的。 Ang II处理诱导依赖于内皮依赖性的收缩响应(EDCF),其被环氧氧基酶(COX)抑制剂吲哚美辛incomethacin废除。在Ang II组中观察到血管氧化胁迫和NADPH氧化酶亚基(P47(PHOX)和P22(PHOX)),COX-1和COX-2的表达水平(P47(PHOX)和P22(PHOX),而Skca和Connexin 37被下调。 EPA的摄入量:DHA 6:1通过改善无-和EDH介导的弛豫和减少eDCF和靶蛋白的表达来防止Ang II诱导的高血压和内皮功能障碍。目前的研究结果表明,EPA的慢性摄入量:DHA 6:1防止了大鼠的Ang II诱导的高血压和内皮功能障碍,最有可能通过预防NADPH氧化酶和COX衍生的氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号